Friday 6 November 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue: −0.28%
EPS: −154.6%
Free cash flow: +38.8%
Total debt: −89.4%

Quarter to September 2026, against a year earlier

19.83 0.86 +4.53%

Follow VTRS

Alert me

Market cap: $21.8B
P/E: 0.0×
Fwd P/E: 82.6×
Dividend yield: 2.54%
F-score: 4/9
Altman Z: 0.61
Beneish M: −3.29
Dividend safety: 37/100

Overview Business Profile Earnings & Analysis Valuation Filings

Viatris Inc. 10-K filed Feb 27, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 27, 2025 · accepted 4:07 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1A, Risk Factors: no comparison — no earlier filing on file